Vysnova Partners Inc. was recently awarded the first task order under the IDIQ W81XWH22D0008 with the Armed Forces Research Institute of Medical Sciences (AFRIMS) Entomology.
Vysnova will support NAMRU-2 in conducting a research project entitled “Identification of gene mutation in the insecticide-resistant mosquito population in Vietnam using next generation sequencing’.
Febrile and Vector Surveillance in Malaysia
TO22F-0125, Febrile and Vector Surveillance in Malaysia, 19 September 2022 - 18 September 2023 This surveillance program will take place at field, hospital and/or clinic sites in Eastern Malaysia, primarily in the state of Sabah, where patients exhibiting Acute Undifferentiated Febrile Illness (AUFI) symptoms can volunteer to participate in the study.
Vysnova Partners, led by acquisition policy development and Federal rule-making expertise Cadre Acquisition Group, has successfully finalized the Department of Transportation’s (DOT) Transportation Acquisition Regulation (TAR) Notice of Proposed Rule-making (NPRM) to Streamline and Update the Department of Transportation Acquisition Regulation (TAR Case 2020–001).
New Task Order: Monitoring the Spread of Multi-drug Resistant Plasmodium Species in Central Vietnam
Vysnova will support NAMRU-2 to fulfill the goals and objectives of the research project “Monitoring the Spread of Multi-drug Resistant Plasmodium Species in Central Vietnam”.
In support of NAMRU-2, Vysnova will provide research support services to fulfill the goals and objectives of the research project “Characterizing Risk at the Poultry-Pig Interface to Strengthen Surveillance for Novel Influenza Viruses in Lao PDR” to further and more completely characterize the practices and processes by which influenza A viruses tend to emerge as a result of animal interactions, trade, and food preparation in rural SEA, and especially in close proximity to the Laotian-Chinese border.
Vysnova’s Team Member Spotlight is on Brooke Willson! Brooke is a Program Management Specialist at the Defense Acquisition University (DAU).
On September 22, 2022, Vysnova Partners Inc. (Vysnova) was awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract for Armed Forces Research Institute of Medical Sciences (AFRIMS) Entomology...
Vysnova Partners is proud to announce that they will be an exhibitor at the Military Health System Research Symposium from September 12-15 in Orlando, Florida.